Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 2/20 | 0.55 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.55 |
| ▸ | LGALS4 | P56470 | 2/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | CD209 | Q9NNX6 | 2/20 | 0.44 |
| ▸ | SELE | P16581 | 1/20 | 0.44 |
| ▸ | CD69 | Q07108 | 1/20 | 0.43 |
| ▸ | HPSE | Q9Y251 | 2/20 | 0.41 |
| ▸ | MDK | P21741 | 2/20 | 0.41 |
| ▸ | AMY2A | P04746 | 2/20 | 0.41 |
| ▸ | PTN | P21246 | 1/20 | 0.41 |
| ▸ | BDNF | P23560 | 1/20 | 0.41 |
| ▸ | IGF2R | P11717 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8744635 | 1.00 | LGALS8 (0.55) | LGALS8LGALS3LGALS4MAPK1CD209 | |
| SCHEMBL8744639 | 0.96 | LGALS8 (0.59) | LGALS8LGALS3LGALS4MAPK1CD209 | |
| SCHEMBL8744641 | 0.96 | LGALS8 (0.59) | LGALS8LGALS3LGALS4MAPK1CD209 | |
| SCHEMBL8744661 | 0.93 | MAPK1 (0.50) | LGALS8LGALS3LGALS4MAPK1SELE | |
| SCHEMBL9473406 | 0.92 | MAPK1 (0.62) | LGALS8LGALS3LGALS4MAPK1CD209 | |
| SCHEMBL9473417 | 0.92 | MAPK1 (0.62) | LGALS8LGALS3LGALS4MAPK1CD209 | |
| SCHEMBL8009126 | 0.91 | MAPK1 (0.66) | LGALS8LGALS3LGALS4MAPK1CD209 | |
| SCHEMBL11220610 | 0.91 | LGALS8 (0.60) | LGALS8LGALS3LGALS4MAPK1SELE | |
| SCHEMBL8009129 | 0.91 | MAPK1 (0.66) | LGALS8LGALS3LGALS4MAPK1CD209 | |
| SCHEMBL9473215 | 0.90 | LGALS8 (0.62) | LGALS8LGALS3LGALS4MAPK1CD69 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0593419-B1 | INHIBITORS FOR GLYCOSAMINOSYL TRANSFERASE-V | ALBERTA RES COUNCIL (CA) | 1997-01-22 | — | — | EP | disclosed |
| US-5206356-A | Therapy and diagnosis of metastatic metabolic states | CHEMBIOMED, LTD. (CA) | 1993-04-27 | — | — | US | disclosed |
| US-5032505-A | Enzyme inhibitors | CHEMBIOMED, LTD. (CA) | 1991-07-16 | — | — | US | disclosed |